YFS Pharma, Inc. Expands In Buffalo, New York Suburb
The project at YFS Pharma, Inc. involves the construction of a 9,467 square foot facility that will allow the company to manufacture products for commercial sale and clinical trials. This is in addition to 6,834 square feet of office space currently being leased in the same facility.
The company currently employs 14 full-time employees, and the expansion will create 28 new jobs. Empire State Development will assist the company with $500,000 in Excelsior Job Program tax credits as an incentive.
"Western New York is rapidly becoming a hub of high-tech manufacturing with businesses choosing to come here and grow and expand in this region," Governor Andrew Cuomo said. "With the addition of 28 new highly skilled jobs at YFS Pharma, we take another step forward to help grow the Buffalo area’s economy, allowing this region to continue to thrive for years to come."
Dr. Satish Sharma, Executive Chairman, You First Services Group of Companies said, "It is the vision of YFS to be a world-class research and development company. We remain committed to developing science and creating global partnerships. These partnerships with like-minded organizations will result in the introduction of unique health care applications that will contribute to decreased health care costs. The company aims to be a global leader in providing innovative health care technologies, and contribute significantly towards social advancement."
Empire State Development President, CEO and Commissioner, Howard Zemsky said, "Western New York is a great place for pharmaceutical companies to do business thanks to distinguished biomedical research institutions, such as the University at Buffalo, its highly skilled workforce, and its growing cluster of biotech companies."
CEO of You First Services Group of Companies John M. Barret said, "The company has successfully launched its flagship product, Lubricity® for moisturizing dry mouth, and will be introducing a second product, MetaQil™, for reducing metallic taste for oncology patients, as well as for patients taking a variety of medications, by the end of the first quarter of 2017. These products, as well as a number of additional products, having approved clinical trials at the Veterans Administration Hospital in Buffalo, Jacksonville University and the State University of New York, will be manufactured by YFS Pharma."
In Focus: “Golden Age” of Spec Development
The 2021 Top States for Doing Business Reflect Their Locational Advantages
Area Development’s 17th Annual Shovel Awards Recognize State and Local Economic Development Efforts — First Two Platinum Shovels Awarded
Explosive Growth of Life Sciences Sector Comes with Challenges
In Focus: Demand for Industrial Land Surges
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
The Evolution of the Megasite